Masimo Co. (NASDAQ:MASI) Shares Bought by MML Investors Services LLC

MML Investors Services LLC lifted its stake in shares of Masimo Co. (NASDAQ:MASI) by 4.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,056 shares of the medical equipment provider’s stock after purchasing an additional 96 shares during the period. MML Investors Services LLC’s holdings in Masimo were worth $274,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in MASI. Edgestream Partners L.P. acquired a new position in Masimo during the second quarter worth $645,000. Simplify Asset Management Inc. raised its holdings in shares of Masimo by 120.4% during the 2nd quarter. Simplify Asset Management Inc. now owns 21,670 shares of the medical equipment provider’s stock worth $2,729,000 after acquiring an additional 11,838 shares during the period. ING Groep NV boosted its position in shares of Masimo by 143.3% during the 3rd quarter. ING Groep NV now owns 240,900 shares of the medical equipment provider’s stock valued at $32,119,000 after acquiring an additional 141,900 shares during the last quarter. Westfield Capital Management Co. LP grew its holdings in shares of Masimo by 23.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider’s stock valued at $185,869,000 after purchasing an additional 262,370 shares during the period. Finally, Thrivent Financial for Lutherans increased its position in Masimo by 42.1% during the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider’s stock worth $153,314,000 after purchasing an additional 360,497 shares during the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MASI has been the subject of several analyst reports. Wells Fargo & Company increased their price target on shares of Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. BTIG Research raised their target price on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Stifel Nicolaus restated a “buy” rating and issued a $190.00 target price (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Wednesday, November 6th. Finally, Piper Sandler boosted their price objective on shares of Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, Masimo currently has an average rating of “Moderate Buy” and an average target price of $175.67.

Masimo Price Performance

MASI opened at $168.31 on Thursday. The firm has a market cap of $9.01 billion, a price-to-earnings ratio of 116.08 and a beta of 1.01. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The stock’s 50-day moving average price is $161.40 and its 200 day moving average price is $135.43. Masimo Co. has a 12-month low of $101.61 and a 12-month high of $180.97.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.14. The firm had revenue of $504.60 million during the quarter, compared to analysts’ expectations of $502.87 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The business’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.63 earnings per share. As a group, sell-side analysts expect that Masimo Co. will post 4.03 earnings per share for the current year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.